Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nimacimab in Patients With Diabetic Gastroparesis
NCT03900325Phase 2Unknown
- Sponsor
- Bird Rock Bio
- Start
- Aug 2019
- Primary completion
- Jan 2020
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of nimacimab in diabetic gastroparesis, sponsored by Bird Rock Bio. Status: unknown.
02
Drugs
nimacimab
03
Conditions
diabetic gastroparesis
Beyond the preview
Go deeper on NCT03900325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03900325.